Acquired central nervous system demyelinating disease is increasingly recognized as a significant contributor to neurologic morbidity in the pediatric population. Recent consensus definitions of the spectrum of acquired demyelinating disorders as wel
No takes yet. Share an insight, caveat, or question.
Tillema et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: